These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17882670)
1. Effects of hormone treatment on hemostasis variables. Kluft C Climacteric; 2007 Oct; 10 Suppl 2():32-7. PubMed ID: 17882670 [TBL] [Abstract][Full Text] [Related]
2. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Eilertsen AL; Sandvik L; Mowinckel MC; Andersen TO; Qvigstad E; Sandset PM Thromb Res; 2007; 120(3):371-9. PubMed ID: 17156824 [TBL] [Abstract][Full Text] [Related]
4. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness. Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483 [TBL] [Abstract][Full Text] [Related]
5. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603 [TBL] [Abstract][Full Text] [Related]
6. Hormone therapy and hemostasis among postmenopausal women: a review. Canonico M Menopause; 2014 Jul; 21(7):753-62. PubMed ID: 24937030 [TBL] [Abstract][Full Text] [Related]
7. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909 [TBL] [Abstract][Full Text] [Related]
8. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases]. Kuhl H Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):653-62. PubMed ID: 1452000 [TBL] [Abstract][Full Text] [Related]
9. Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. Eilertsen AL; Qvigstad E; Andersen TO; Sandvik L; Sandset PM Maturitas; 2006 Oct; 55(3):278-87. PubMed ID: 16713143 [TBL] [Abstract][Full Text] [Related]
10. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study. Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability. Skouby SO; Sidelmann JJ; Nilas L; Jespersen J Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528 [TBL] [Abstract][Full Text] [Related]
12. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens. Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317 [TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy use and variations in the risk of breast cancer. Opatrny L; Dell'Aniello S; Assouline S; Suissa S BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598 [TBL] [Abstract][Full Text] [Related]
14. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143 [TBL] [Abstract][Full Text] [Related]
16. Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study. Sgarabotto M; Baldini M; Dei Cas A; Manotti C; Luciana Barilli A; Rinaldi M; Benassi L; Bacchi Modena A Thromb Res; 2007; 119(1):85-91. PubMed ID: 16499954 [TBL] [Abstract][Full Text] [Related]
17. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. Eilertsen AL; Karssemeijer N; Skaane P; Qvigstad E; Sandset PM BJOG; 2008 May; 115(6):773-9. PubMed ID: 18355366 [TBL] [Abstract][Full Text] [Related]
18. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article. Lakoski SG; Herrington DM Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766 [TBL] [Abstract][Full Text] [Related]
19. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
20. Hormone therapy and venous thromboembolism among postmenopausal women. Scarabin PY Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]